Hepatic Resection for Hepatocellular Carcinoma in the Era of Molecular-targeted Agents and Immune Checkpoint Inhibitors in Japan

Hepatic resection or liver transplantation for hepatocellular carcinoma (HCC) represents the only chance for achieving a cure. For the past several decades in Japan, aggressive hepatic resection has been performed for advanced HCC, with consequent good outcomes. According to the 21st Nationwide Foll...

Descripción completa

Detalles Bibliográficos
Autor principal: Taketomi, Akinobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Medical Association 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355680/
https://www.ncbi.nlm.nih.gov/pubmed/34414318
http://dx.doi.org/10.31662/jmaj.2021-0035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355680/
https://www.ncbi.nlm.nih.gov/pubmed/34414318
http://dx.doi.org/10.31662/jmaj.2021-0035

Ejemplares similares